Stay updated on Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s footer revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version refresh without changing the underlying clinical trial record history content.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision history updated: added Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedRecord History now shows the addition of revision v3.5.0 and the deletion of revision v3.4.3.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded revision v3.4.3 and removed v3.4.2 in the page history.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded system revision v3.4.2 and removed the funding-status notice (v3.4.1); no changes to study data or core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check91 days agoChange DetectedA site-wide funding notice is now displayed and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

Stay in the know with updates to Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enzalutamide Combo in Metastatic Prostate Cancer Clinical Trial page.